Article Details

HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169 Million

Retrieved on: 2021-03-24 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169 Million. View article details on hiswai:

Excerpt

... us to focus our organization and resources on our primary aim of accelerating investment in our Oncology/Immunology assets in China and beyond.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up